# “Algal-dromes”: a novel conceptual approach to illness in humans exposed to harmful algal bloom toxins

**Authors:** Brett Johnson, Mindy Richlen, Jeffrey Lai, Michael J. Twiner

PMC · DOI: 10.3389/ftox.2026.1749427 · Frontiers in Toxicology · 2026-03-13

## TL;DR

This paper introduces the concept of 'algal-dromes' to describe illnesses caused by harmful algal bloom toxins and highlights the growing public health concern due to increasing human exposure.

## Contribution

The paper introduces the novel term 'algal-dromes' to categorize syndromes caused by algal toxins.

## Key findings

- Known human exposure to HAB toxins is increasing due to environmental changes and coastal development.
- Current management of algal poisoning relies on expert opinion and lacks standardized treatment strategies.
- The paper reviews major algal toxins and their associated health effects.

## Abstract

Although adverse health effects from harmful algal bloom (HAB) toxins have been described since antiquity, the true worldwide incidence and disease burden has yet to be defined. This is in part due to lack of reporting and under-recognition of exposure. Furthermore, when human exposure does occur, there exists little consensus on optimal treatment strategies for specific HAB events or confirmatory laboratory testing capabilities. Current management strategies largely rely on primary prevention through public health efforts, often undertaken at the state and local level. As serious illness is rare, current management of acute algal poisoning is mostly based on expert opinion and case reporting. Despite this, known incidence of human exposure to HAB toxins is increasing due to shifting environmental conditions, rising global seafood demand, and growing population density and development along coastal and freshwater bodies. This rise in human exposures underscores the pressing public health need to address current knowledge gaps. This paper provides a comprehensive review of many of the major algal toxins (specifically ciguatoxin, saxitoxin, azaspiracid, brevetoxin, okadaic acid, dinophysistoxin, domoic acid, and cyanotoxins), the management strategies associated with suspected poisoning, and presents a novel term to describe the unique syndromes associated with their illness; “algal-dromes.”

## Linked entities

- **Chemicals:** ciguatoxin (PubChem CID 5311333), saxitoxin (PubChem CID 56947150), azaspiracid (PubChem CID 21593892), brevetoxin (PubChem CID 46881333), okadaic acid (PubChem CID 446512), domoic acid (PubChem CID 5282253)

## Full-text entities

- **Diseases:** poisoning (MESH:D011041)
- **Chemicals:** HAB toxins (-), domoic acid (MESH:C012301), azaspiracid (MESH:C406592), saxitoxin (MESH:D012530), ciguatoxin (MESH:D002922), okadaic acid (MESH:D019319), brevetoxin (MESH:C053342)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13021141/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13021141/full.md

## References

116 references — full list in the complete paper: https://tomesphere.com/paper/PMC13021141/full.md

---
Source: https://tomesphere.com/paper/PMC13021141